首页> 外文期刊>Journal of microbiology, immunology, and infection: Wei mian yu gan ran za zhi >Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU
【24h】

Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU

机译:鲍曼不动杆菌和不动杆菌基因组物种13TU的GyrA和ParC喹诺酮耐药性决定区的氨基酸取代与喹诺酮耐药性相关

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: Amino acid substitutions in GyrA and ParC are associated with resistance to quinolones in Acinetobacter baumannii (A baumannii), but this association is rarely elucidated in Acinetobacter genomic species (AGS) 13TU. This study aims to compare the association of amino acid substitutions in GyrA and ParC with quinolone resistance in A baumannii and AGS 13TU in Taiwan. Methods: Eleven representative strains of A baumannii and 13 strains of AGS 13TU were selected from 402 bacteremic isolates. The sequences of quinolone resistance determining regions of gyrA and parC were determined. Minimal inhibitory concentrations (MICs) of nalidixic acid, ciprofloxacin, levofloxacin and moxifloxacin were determined by agar dilution method. Results: Ser83Leu substitution in GyrA in A baumannii (one strain) was associated with resistance to all tested quinolones. This substitution plus a Ser80Leu or Ser80Tyr in ParC in A baumannii (four strains) and AGS 13TU (two strains) were associated with higher MICs of all quinolones. All but one quinolone MICs of A baumannii (one strain) and AGS 13TU (two strains) carrying a single substitution Ser56Asn in ParC remained in the susceptibility breakpoint. The Ser83Leu substitution in GyrA, even with additional Ser56Asn substitution in ParC, was associated with resistance to only nalidixic acid, but not other newer quinolones in AGS 13TU (two strains). Conclusion: A baumannii and AGS 13TU possessed similar quinolone resistance associated with amino acid substitutions in GyrA and ParC. Further study with more strains is needed to determine whether a single Ser83Leu substitution in GyrA was associated with a high level of quinolone MIC only in A baumannii, but not in AGS 13TU.
机译:背景与目的:GyrA和ParC中的氨基酸取代与鲍曼不动杆菌(A baumannii)中的喹诺酮类耐药性相关,但在不动杆菌基因组物种(AGS)13TU中很少阐明这种关联。本研究旨在比较GyrA和ParC中氨基酸取代与台湾鲍曼不动杆菌和AGS 13TU中喹诺酮耐药性的关系。方法:从402株细菌中分离出11株鲍曼不动杆菌代表性菌株和13株AGS 13TU。确定了gyrA和parC的喹诺酮抗性确定区域的序列。琼脂稀释法测定萘啶酸,环丙沙星,左氧氟沙星和莫西沙星的最低抑菌浓度(MIC)。结果:鲍曼不动杆菌(一种菌株)GyrA中的Ser83Leu取代与对所有测试喹诺酮类药物的耐药性相关。在鲍曼不动杆菌(四个菌株)和AGS 13TU(两个菌株)的ParC中,这种取代加上Ser80Leu或Ser80Tyr与所有喹诺酮类药物的MIC较高有关。在ParC中携带单个取代Ser56Asn的鲍曼不动杆菌(一种菌株)和AGS 13TU(两种菌株)的喹诺酮类MIC均保持在敏感性临界点。 GyrA中的Ser83Leu取代,甚至在ParC中具有另外的Ser56Asn取代,都与仅对萘啶酸的抗性有关,而对AGS 13TU(两种菌株)中其他较新的喹诺酮类药物没有抗性。结论:鲍曼氏菌和AGS 13TU具有相似的喹诺酮耐药性,与GyrA和ParC中的氨基酸取代有关。需要对更多菌株进行进一步研究,以确定GyrA中单个Ser83Leu取代是否仅与鲍曼不动杆菌中高水平的喹诺酮MIC相关,而在AGS 13TU中则不相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号